Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000093751-25-000644
Filing Date
2025-11-10
Accepted
2025-11-10 09:04:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5935
  Complete submission text file 0000093751-25-000644.txt   8109
Mailing Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114
Business Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

EIN.: 042456637 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6022 State Commercial Banks
(CF Office: 02 Finance)

Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Subject) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-87868 | Film No.: 251464716
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)